|

TNX-103 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 3: 2

Top Sponsors

  • Tenax Therapeutics, Inc.2

Indications

  • Heart Disease2
  • Pulmonary Hypertension Associated With HFpEF1
  • Pulmonary Hypertension1

Alexander City, Alabama1 trial

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Tenax Investigational Site

Phase 3

Tucson, Arizona1 trial

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Tenax Investigational Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.